Highlights from the week of 17th Aug - 24th Aug Biocon ( FDA, Approval ) Biocon receives approval from FDA for YESINTEK 45 mg/0.5 mL and 90 mg/mL single-dose prefilled autoinjectors to treat adult and pediatrics with psoriasis, and adults with CD and UC Regeneron ( FDA, Approval ) Regeneron gets FDA approval for PASATRU, indicated to reduce the formation of new HO lesions and clinician-assessed flare-ups in adults with FOP Ultragenyx ( FDA, Accelerated Approval ) FDA grants accelerated approval for Ultragenyx's DTX401, indicated to treat GSDIa in adults and pediatrics Johnson&Johnson ( EU, Approval ) J&J receives indication extension approval from EC for TECVAYLI in combination with daratumumab to treat adults with RRMM who received at least one prior therapy All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 17th August – 24th August in the world of pharma and healthcare!

Uncategorized /

Highlights from the Week of 17th August – 24th August in the world of pharma and healthcare! Read More »